DCT

1:21-cv-01485

Boehringer Ingelheim Pharma Inc v. Lupin Ltd

General

Filed

10/22/21

Cause of ActionPatent Infringement

SectorBiotech

StatusOpen

Patent Owner

Operating Company

Nature of Suit835 ANDA

Judge	Period	PO Win Rate
Colm F. Connolly	--	40%

Plaintiff

Party

Name	Ratings
Boehringer-Ingelheim Pharmaceuticals Inc NPE	L4A
Boehringer Ingelheim Pharmaceuticals Inc NPE	L4A
Boehringer Ingelheim Corp NPE	L4A
Boehringer Ingelheim Intl GmbH	L4A

Attorney

Name	Ratings
Morris Nichols Arsht & Tunnell LLPLocal	L5A
Jack B. Blumenfeld	L5A
Brian P. Egan	L5B
Megan Dellinger	L5B
Kirkland & Ellis LLP	L5A
Bryan S. Hales	L5A
Mira A. Mulvaney	L5C
Jeanna Wacker	L5E
James F. Hurst	L5E
Sam Kwon	L4C
Ashley L. B. Ross	L4C

Defendant

Party

Name	Ratings
Aurobindo Pharma USA Inc	L5E
Lupin Pharmaceuticals Inc	L5E
Lupin Ltd	L5E
Mankind Pharma Ltd	L1E
Sun Pharmaceutical Industries Ltd	L5E
Ohm Laboratories Inc	L5E
DR Reddys Laboratories Inc	L4D
Laurus Labs Ltd	L2D
Laurus Generics Inc	L2D
Lifestar Pharma LLC	L1E

Attorney

Name	Ratings
Winston & Strawn LLP	L5B
Charles B. Klein	L5D
Jovial Wong	L5E
Michael K. Nutter	L5E
Jason Pesick	L4C
Kevin J. Boyle	L3C
Connolly Bove Lodge & Hutz	L4B
Arthur G. Connolly, III	L5E
Blank Rome LLP	L4B
Dipu A. Doshi	L5E
Adam V. Orlacchio	L4D
Jay P. Lessler	L4E
Anna E. Currier	---- --
Serena S. Gopal	---- --
Phillips Goldman McLaughlin & Hall PALocal	L4E
John C. Phillips, Jr.	L5E
David A. Bilson	L5E
Young Conaway Stargatt & Taylor LLPLocal	L4E
Adam W. Poff	L5E
Alexis Stombaugh	L3E
Withers Bergman	L1E
Lina Genovesi	---- --